MSGRDirexion mRNA ETF
MSGR Fund Description
MSGR tracks a market-cap-weighted index of companies from the US, Canada, and Europe that contribute to the development and application of messenger RNA (mRNA) technology.
MSGR Factset Analytics Insight
MSGR targets a very niche segment of the healthcare sector. The fund is passively managed to look for firms listed in the US, Canada, and Europe that are believed to be in the forefront of mRNA technology. To be included in the index, a company must be either (i) involved in the commercialization of mRNA-based (or sister RNA-based) products and therapies, (ii) classified as a clinical stage biotech company with a focus on mRNA technology, (iii) have mRNA-focused clinical trials, or (iv) have patents involving mRNA technology. Eligible companies are screened for significant thematic exposure, which is scored according to revenue, declared focus, or clinical trials on mRNA-based products and therapies. The index weights the resulting portfolio by market capitalization and undergoes quarterly reconstitution and rebalancing.
MSGR Summary Data
MSGR Portfolio Data
MSGR Index Data
MSGR Portfolio Management
MSGR Tax Exposures
MSGR Fund Structure
MSGR Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of MSGR. MSGR is rated a N/A out of 5.
MSGR Top 10 Holdings[View All]
MSGR Performance Statistics
MSGR Benchmark Comparison Summary
MSGR Benchmark Comparison Market Cap Size
Options Strategies for Outcome Investing
A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security.
A covered call is an income strategy constructed by writing a call option against a holding of the underlying security.